Is intramuscular testosterone injection more effective than topical testosterone gel?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Testosterone injections are generally more effective than gels for raising testosterone levels, and clinicians should consider intramuscular rather than transdermal formulations when initiating testosterone treatment due to lower costs and similar clinical effectiveness and harms. According to a clinical guideline from the American College of Physicians 1, intramuscular formulations, such as injections, are recommended over transdermal formulations, like gels, for improving sexual function in men with age-related low testosterone. This recommendation is based on the lower costs of intramuscular formulations, with an annual cost of $156.24 compared to $2135.32 for transdermal formulations, as well as similar clinical effectiveness and harms 1.

Some key points to consider when choosing between testosterone injections and gels include:

  • Injections typically provide higher and more consistent testosterone levels in the bloodstream compared to topical gels 1
  • Injectable testosterone is usually administered every 1-2 weeks and delivers a more immediate impact on hormone levels
  • Testosterone gel must be applied daily and has variable absorption rates depending on skin condition, application technique, and potential transfer risks
  • Injections also tend to be more cost-effective over time, with a significant difference in annual cost between intramuscular and transdermal formulations 1
  • Side effects are similar between both forms, including potential acne, mood changes, and cardiovascular risks, though gels carry the additional risk of transferring testosterone to others through skin contact

Ultimately, the choice between testosterone injections and gels should be based on individual patient preferences and needs, and clinicians should discuss the potential benefits, harms, costs, and patient's preferences when initiating testosterone treatment 1.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Comparison of Testosterone Shot and Gel

  • The provided studies do not directly compare the effectiveness of testosterone shots and gels 2, 3, 4, 5, 6.
  • However, study 4 evaluates the efficacy and safety of a new topical testosterone replacement gel therapy for the treatment of male hypogonadism, showing that approximately three-quarters (76.1%) of subjects met the average testosterone concentration criteria on Day 90.
  • Study 5 assesses the efficacy and safety of testosterone gel treatment in hypogonadal men with liver cirrhosis, finding that testosterone replacement resulted in an increase in muscle strength and amelioration of gynecomastia.
  • There is no direct evidence to suggest that testosterone shots are more effective than gels, as the studies focus on the efficacy and safety of gel treatments or discuss guidelines for testosterone replacement therapy in general 2, 3, 6.

Efficacy and Safety of Testosterone Gel

  • Testosterone gel has been shown to be effective in improving symptoms of testosterone deficiency, with few safety concerns 4, 5.
  • Study 5 found that testosterone gel treatment raised free testosterone to values below supraphysiological levels in cirrhotic men, improving muscle strength and ameliorating gynecomastia.
  • The safety profile of testosterone gel is favorable, with most adverse events being mild to moderate 4.

Guidelines for Testosterone Replacement Therapy

  • The Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism emphasize the importance of diagnosing men who are androgen deficient due to organic hypogonadism 2.
  • The US Endocrine Society and Endocrine Society of Australia provide guidelines for testosterone therapy, highlighting the importance of identifying pre-existing prostate and cardiovascular disease prior to initiating therapy 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

EFFICACY AND SAFETY OF A NEW TOPICAL TESTOSTERONE REPLACEMENT GEL THERAPY FOR THE TREATMENT OF MALE HYPOGONADISM.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2017

Research

Effects of testosterone gel treatment in hypogonadal men with liver cirrhosis.

Clinics and research in hepatology and gastroenterology, 2011

Research

Testosterone in men with advanced liver disease: abnormalities and implications.

Journal of gastroenterology and hepatology, 2015

Related Questions

Is it safe for a patient with stage 3 liver fibrosis to continue low-dose testosterone (testosterone) therapy for hypogonadism?
What are the considerations for testosterone replacement therapy in males with hepatic (liver) cirrhosis?
What is the treatment for elevated liver enzymes and high testosterone levels?
What are the risks and management strategies for cholestatic liver disease in young to middle-aged men with a history of hypogonadism taking testosterone supplements for performance enhancement or treatment?
What is an androgen panel?
What is kyphoplasty?
What is the best treatment for a 20-year-old obese male with psychotic depression, characterized by non-command auditory hallucinations and paranoid persecutory delusions, and a 5-year history of chronic Major Depressive Disorder (MDD)?
Is there a point in checking Plasma Aldosterone Concentration (PAC) in patients with Primary Aldosteronism (PA) treated with Spironolactone (spironolactone)?
What is the management for a patient with a fresh horse bite wound, open fracture, and contamination?
What is the appropriate management for a 16-year-old patient with a past medical history (PMH) of depression, currently treated with Prozac (fluoxetine) 20mg, who reports a good response to treatment and no adverse effects, and is requesting medication refills?
What additional testing or treatment is needed for an 88-year-old patient with glycosuria, no prior history of diabetes mellitus, and currently being treated with Farxiga (dapagliflozin) for congestive heart failure (CHF)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.